BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 30890699)

  • 1. Bone marrow-derived mesenchymal stem cells promote colorectal cancer progression via CCR5.
    Nishikawa G; Kawada K; Nakagawa J; Toda K; Ogawa R; Inamoto S; Mizuno R; Itatani Y; Sakai Y
    Cell Death Dis; 2019 Mar; 10(4):264. PubMed ID: 30890699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCR5/CCR5 ligand-induced myeloid-derived suppressor cells are related to the progression of endometriosis.
    Guo P; Bi K; Lu Z; Wang K; Xu Y; Wu H; Cao Y; Jiang H
    Reprod Biomed Online; 2019 Oct; 39(4):704-711. PubMed ID: 31427176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential Molecular Cross Talk Among CCR5 Pathway Predicts Regorafenib Responsiveness in Metastatic Colorectal Cancer Patients.
    Suenaga M; Zhang WU; Mashima T; Schirripa M; Cao S; Okazaki S; Berger MD; Miyamoto Y; Barzi A; Yamaguchi T; Lenz HJ
    Cancer Genomics Proteomics; 2021; 18(3):317-324. PubMed ID: 33893084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between chemokines CCL2, CCL3, and CCL4 with the tumor microenvironment and tumor-associated macrophage markers in colorectal cancer.
    De la Fuente López M; Landskron G; Parada D; Dubois-Camacho K; Simian D; Martinez M; Romero D; Roa JC; Chahuán I; Gutiérrez R; Lopez-K F; Alvarez K; Kronberg U; López S; Sanguinetti A; Moreno N; Abedrapo M; González MJ; Quera R; Hermoso-R MA
    Tumour Biol; 2018 Nov; 40(11):1010428318810059. PubMed ID: 30419802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential regulatory effects of chemotherapeutic protocol on CCL3_CCL4_CCL5/CCR5 axes in acute myeloid leukemia patients with monocytic lineage.
    Yazdani Z; Mousavi Z; Ghasemimehr N; Kalantary Khandany B; Nikbakht R; Jafari E; Fatemi A; Hassanshahi G
    Life Sci; 2020 Jan; 240():117071. PubMed ID: 31783051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCR5-Mediated Signaling Is Involved in Invasion of Glioblastoma Cells in Its Microenvironment.
    Novak M; Koprivnikar Krajnc M; Hrastar B; Breznik B; Majc B; Mlinar M; Rotter A; Porčnik A; Mlakar J; Stare K; Pestell RG; Lah Turnšek T
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32545571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-infiltrating monocytic myeloid-derived suppressor cells mediate CCR5-dependent recruitment of regulatory T cells favoring tumor growth.
    Schlecker E; Stojanovic A; Eisen C; Quack C; Falk CS; Umansky V; Cerwenka A
    J Immunol; 2012 Dec; 189(12):5602-11. PubMed ID: 23152559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antineoplastic effects of targeting CCR5 and its therapeutic potential for colorectal cancer liver metastasis.
    Pervaiz A; Zepp M; Georges R; Bergmann F; Mahmood S; Faiza S; Berger MR; Adwan H
    J Cancer Res Clin Oncol; 2021 Jan; 147(1):73-91. PubMed ID: 32902795
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Battaglin F; Baca Y; Millstein J; Yang Y; Xiu J; Arai H; Wang J; Ou FS; Innocenti F; Mumenthaler SM; Jayachandran P; Kawanishi N; Lenz A; Soni S; Algaze S; Zhang W; Khoukaz T; Roussos Torres E; Seeber A; Abraham JP; Lou E; Philip PA; Weinberg BA; Shields AF; Goldberg RM; Marshall JL; Venook AP; Korn WM; Lenz HJ
    J Immunother Cancer; 2024 Jan; 12(1):. PubMed ID: 38212126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of circulating concentrations of chemokine receptor CCR5 ligands to C-peptide, proinsulin and HbA1c and disease progression in type 1 diabetes.
    Pfleger C; Kaas A; Hansen L; Alizadeh B; Hougaard P; Holl R; Kolb H; Roep BO; Mortensen HB; Schloot NC;
    Clin Immunol; 2008 Jul; 128(1):57-65. PubMed ID: 18434252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCR5 ligands modulate CXCL12-induced chemotaxis, adhesion, and Akt phosphorylation of human cord blood CD34+ cells.
    Basu S; Broxmeyer HE
    J Immunol; 2009 Dec; 183(11):7478-88. PubMed ID: 19917679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. G-protein-coupled receptor screen reveals a role for chemokine receptor CCR5 in suppressing microglial neurotoxicity.
    Gamo K; Kiryu-Seo S; Konishi H; Aoki S; Matsushima K; Wada K; Kiyama H
    J Neurosci; 2008 Nov; 28(46):11980-8. PubMed ID: 19005063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 27-Hydroxycholesterol and 7alpha-hydroxycholesterol trigger a sequence of events leading to migration of CCR5-expressing Th1 lymphocytes.
    Kim SM; Kim BY; Lee SA; Eo SK; Yun Y; Kim CD; Kim K
    Toxicol Appl Pharmacol; 2014 Feb; 274(3):462-70. PubMed ID: 24370436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fat-storing multilocular cells expressing CCR5 increase in the thymus with advancing age: potential role for CCR5 ligands on the differentiation and migration of preadipocytes.
    Mello Coelho Vd; Bunbury A; Rangel LB; Giri B; Weeraratna A; Morin PJ; Bernier M; Taub DD
    Int J Med Sci; 2009 Dec; 7(1):1-14. PubMed ID: 20046229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virus stimulation of human mast cells results in the recruitment of CD56⁺ T cells by a mechanism dependent on CCR5 ligands.
    McAlpine SM; Issekutz TB; Marshall JS
    FASEB J; 2012 Mar; 26(3):1280-9. PubMed ID: 22125314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular anatomy of CCR5 engagement by physiologic and viral chemokines and HIV-1 envelope glycoproteins: differences in primary structural requirements for RANTES, MIP-1 alpha, and vMIP-II Binding.
    Navenot JM; Wang ZX; Trent JO; Murray JL; Hu QX; DeLeeuw L; Moore PS; Chang Y; Peiper SC
    J Mol Biol; 2001 Nov; 313(5):1181-93. PubMed ID: 11700073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human MSCs promotes colorectal cancer epithelial-mesenchymal transition and progression via CCL5/β-catenin/Slug pathway.
    Chen K; Liu Q; Tsang LL; Ye Q; Chan HC; Sun Y; Jiang X
    Cell Death Dis; 2017 May; 8(5):e2819. PubMed ID: 28542126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Species selectivity of small-molecular antagonists for the CCR5 chemokine receptor.
    Saita Y; Kondo M; Shimizu Y
    Int Immunopharmacol; 2007 Dec; 7(12):1528-34. PubMed ID: 17920529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer cell CCL5 mediates bone marrow independent angiogenesis in breast cancer.
    Sax MJ; Gasch C; Athota VR; Freeman R; Rasighaemi P; Westcott DE; Day CJ; Nikolic I; Elsworth B; Wei M; Rogers K; Swarbrick A; Mittal V; Pouliot N; Mellick AS
    Oncotarget; 2016 Dec; 7(51):85437-85449. PubMed ID: 27863423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rubratoxin-B-induced secretion of chemokine ligands of cysteine-cysteine motif chemokine receptor 5 (CCR5) and its dependence on heat shock protein 90 in HL60 cells.
    Nagashima H
    Environ Toxicol Pharmacol; 2015 Nov; 40(3):997-1000. PubMed ID: 26595743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.